» Articles » PMID: 36826052

Molecular Aspects of Hypoxic Stress Effects in Chronic Ethanol Exposure of Neuronal Cells

Abstract

Experimental models of a clinical, pathophysiological context are used to understand molecular mechanisms and develop novel therapies. Previous studies revealed better outcomes for spinal cord injury chronic ethanol-consuming patients. This study evaluated cellular and molecular changes in a model mimicking spinal cord injury (hypoxic stress induced by treatment with deferoxamine or cobalt chloride) in chronic ethanol-consuming patients (ethanol-exposed neural cultures (SK-N-SH)) in order to explain the clinical paradigm of better outcomes for spinal cord injury chronic ethanol-consuming patients. The results show that long-term ethanol exposure has a cytotoxic effect, inducing apoptosis. At 24 h after the induction of hypoxic stress (by deferoxamine or cobalt chloride treatments), reduced ROS in long-term ethanol-exposed SK-N-SH cells was observed, which might be due to an adaptation to stressful conditions. In addition, the HIF-1α protein level was increased after hypoxic treatment of long-term ethanol-exposed cells, inducing fluctuations in its target metabolic enzymes proportionally with treatment intensity. The wound healing assay demonstrated that the cells recovered after stress conditions, showing that the ethanol-exposed cells that passed the acute step had the same proliferation profile as the cells unexposed to ethanol. Deferoxamine-treated cells displayed higher proliferative activity than the control cells in the proliferation-migration assay, emphasizing the neuroprotective effect. Cells have overcome the critical point of the alcohol-induced traumatic impact and adapted to ethanol (a chronic phenomenon), sustaining the regeneration process. However, further experiments are needed to ensure recovery efficiency is more effective in chronic ethanol exposure.

Citing Articles

Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations.

Petagine L, Zariwala M, Somavarapu S, Chan S, Kaya E, Patel V Sci Rep. 2025; 15(1):7752.

PMID: 40044747 PMC: 11882943. DOI: 10.1038/s41598-025-91139-0.


Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma.

Miao Y, Wang X, Lai Y, Huang Y, Yin H, Meng X Int J Oncol. 2023; 63(1).

PMID: 37264968 PMC: 10552700. DOI: 10.3892/ijo.2023.5530.

References
1.
Krishnan H, Zhang H, Chen Y, Bohnsack J, Shieh A, Kusumo H . Unraveling the epigenomic and transcriptomic interplay during alcohol-induced anxiolysis. Mol Psychiatry. 2022; 27(11):4624-4632. PMC: 9734037. DOI: 10.1038/s41380-022-01732-2. View

2.
Tibbetts R, Brumbaugh K, Williams J, Sarkaria J, Cliby W, Shieh S . A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999; 13(2):152-7. PMC: 316393. DOI: 10.1101/gad.13.2.152. View

3.
Onose G, Anghelescu A, Blendea C, Ciobanu V, Daia C, Firan F . Non-invasive, non-pharmacological/bio-technological interventions towards neurorestoration upshot after ischemic stroke, in adults-systematic, synthetic, literature review. Front Biosci (Landmark Ed). 2021; 26(11):1204-1239. DOI: 10.52586/5020. View

4.
Lloyd R, Erickson L, Jin L, Kulig E, Qian X, Cheville J . p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999; 154(2):313-23. PMC: 1850003. DOI: 10.1016/S0002-9440(10)65277-7. View

5.
Aviram M, Rosenblat M . Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med. 2004; 37(9):1304-16. DOI: 10.1016/j.freeradbiomed.2004.06.030. View